Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer

Radiotherapy and Oncology

Volumn 53, Issue 3, 1999, Pages 247-255

  Senan, Suresh ^a   Van Sörnsen De Koste, John ^a   Samson, Michael ^a   Tankink, Hans ^a   Jansen, Peter ^a   Nowak, Peter J C M ^a   Krol, Augustinus D G ^a   Schmitz, Paul ^a   Lagerwaard, Frank J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Conformal radiotherapy; Inter clinician variability; Non small cell lung cancer; Target contouring

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGE ANALYSIS; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; CONTRAST MEDIA; EVALUATION STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; LUNG; LUNG NEOPLASMS; MEDIASTINUM; NEOPLASM STAGING; OBSERVER VARIATION; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0345580333     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(99)00143-7     Document Type: Article

References (26)

1. Armstrong J.G. Target volume definition for 3-dimensional conformal radiation therapy of lung cancer. Br. J. Radiol. 71:1998;587-594.
2. Bland J.M., Altman D.G. Measurement error. Br. Med. J. 313:1996;744-753.
3. Bland J.M., Altman D.G. Measurement error and correlation coefficients. Br. Med. J. 313:1996;41-42.
4. Cazzaniga L.F., Marinoni M.A., Bossi A., et al. Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles. Radiother. Oncol. 47:1998;293-296.
5. Debois M., Fossard A., Vansteenkiste J., et al. Impact of PET scan on the target volume in lung cancer radiotherapy planning. Radiother. Oncol. 48:1998;S13.
6. Ekberg L., Holmberg O., Wittgren L., Bjelkengren G., Landberg T. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? Radiother. Oncol. 48:1998;71-77.
7. Graham M.V., Matthews J.W., Harms W.B. Sr, Emami B., Glazer H.S., Purdy J.A. Three-dimensional radiation treatment planning study for patients with carcinoma of the lung. Int. J. Radiat. Oncol. Biol. Phys. 29:1994;1105-1117.
8. Hamilton C.S., Denham J.W., Joseph D.J., et al. Treatment and planning decisions in non-small cell carcinoma of the lung: an Australasian patterns of practice study. Clin. Oncol. 4:1992;141-147.
9. Harris K.M., Adams H., Lloyd D.C., Harvey D.J. The effect on apparent size of simulated pulmonary nodules of using three standard CT window settings. Clin. Radiol. 47:1993;241-244.
10. Hayman J.A., Martel M.K., Ten Haken R.K., Todd R.F., Turrisi A.T., Lichter A.S. Dose escalation in non-small cell lung cancer using conformal 3-dimensional radiation therapy: update of a phase I trial. J. Clin. Oncol. 18:1999;459a (abstract).
11. Hopper K.D., Kasales C.J., Van Slyke M.A., Schwartz T.A., Ten Have T.R., Jozefiak J.A. Analysis of interobserver and intraobserver variability in CT tumour measurements. Am. J. Roentgenol. 167:1996;851-854.
12. International Commission on Radiation Units and Measurements: Prescribing, recording and reporting photon beam therapy. ICRU Report 50, Bethesda, MD, 1993.
13. Ketting C.H., Austin-Seymour M., Kalet I., Unger J., Hummel S., Jacky J. Consistency of three-dimensional planning target volumes across physicians and institutions. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;445-453.
14. Leunens G., Menten J., Weltens C., Verstraete J., van der Schueren E. Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours. Radiother. Oncol. 29:1993;169-175.
15. Logue J.P., Sharrock C.L., Cowan R.A., Read G., Marrs J., Mott D. Clinical variability of target volume description in conformal radiotherapy planning. Int. J. Radiat. Oncol. Biol. Phys. 41:1998;929-931.
16. McNee S.G., Rampling R., Dale A.J., Gregor A. An audit of 3D treatment planning facilities and practice in the UK. Clin. Oncol. 10:1998;18-23.
17. Mountain C.F., Dresler C.M. Regional lymph node classification for lung cancer staging. Chest. 111:6:1997;1718-1723.
18. Purdy J.A., Harms W.B., Michalski J., Bosch W.R. Initial experience with quality assurance of multi-institutional 3D radiotherapy clinical trials. A brief report. Strahlenther Onkol. 174:(Suppl 2):1998;40-42.
19. Quint L.E., Francis I.R., WahI R.L., Gross B.H., Glazer G.M. Preoperative staging of non-small cell carcinoma of the lung: imaging methods. Am. J. Roentgenol. 164:1995;1349-1359.
20. Robertson J.M., Ten Haken R.K., Hazuka M.B., et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;1079-1085.
21. Stroom J.C., Korevaar G.A., Koper P.C., Visser A.G., Heijmen B.J. Multiple two-dimensional versus three-dimensional PTV definition in treatment planning for conformal radiotherapy. Radiother. Oncol. 47:1998;297-302.
22. Tai P., Van Dyk J., Yu E., Battista J., Stitt L., Coad T. Variability of target volume delineation in cervical oesophageal cancer. Int. J. Radiat. Oncol. Biol. Phys. 42:1998;277-288.
23. Van Houtte P., Gregor A., Philips P. International survey of radiotherapy practice for radical treatment of non-small cell lung cancer. Lung Cancer. 3:1994;S129-138.
24. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., et al. Lymph node staging in non-small cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J. Clin. Oncol. 16:1998;2142-2149.
25. Vijayakumar S., Chen G.T. Implementation of three dimensional conformal radiation therapy: prospects, opportunities, and challenges. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;979-983.
26. Weltens C., Menten J., Feron M., et al. Interobserver variations in gross tumour volume delineation of brain tumours on CT and impact of MRI. Radiother. Oncol. 48:1998;S1.